PDF

The Succession Plan: Using Competency-Based Curriculums to Educate a New Generation of Nurse Leaders
Cheryl Green; Evelyn Jacovino MSN, RN, CMSNL; Beth Boyd DNP, RN, CNE; Amy Ashman MSN, RN; John Cooper RN; and Michele Velush BSN, RN, PCCN

Link

The Utility of a Critical Antibody Titer in Anti-K Alloimmunized Pregnancies: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy
Jeremy W. Jacobs, Ronan P. Sugru, Jerome Jeffrey Federspiel, Melissa C. Funaro, Brian D. Adkins, Garrett S. Booth, Christopher Haas, Masja de Hass, Jia Jennifer Ding, Danijela Drndarevic, Sejal Kabre, Shengxin Liu, Yolentha M. Slootweg, Elenor Tiblad, Kenneth J. Moise, and Elizabeth A. Abels

PDF

Adipose Injectable Filler With Use of Meshed Dermal Matrix and Porcine Urinary Bladder Matrix For the Management of a Complex Achilles Wound
Francois M. Lokenye DPM; Orlexia Thomas DPM; Mariam Kamil BS; and Lady Paula DeJesus DPM, FACFAS, FACPM, DWSP

PDF

Complete Closure of Chronic Ankle Ulcerations In the Presence of Lymphadema with Use of Adipose Stem Cell Injectable Allograft, A Case Report
Orlexia Thomas DPM; Francois M. Lokenye DPM; Jasmine Sheikh BS; and Lady Paula DeJesus DPM, FACFAS, FACPM, DWSP

Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo
Carlton L. Schwab, Diana P. English, Jonathan Black, Stefania Bellone, Salvatore Lopez, Emiliano Cocco, Elena Bonazzoli, Beatrice Bussi, Federica Predolini, Francesca Ferrari, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Thomas Rutherford, Peter E. Schwartz, and Alessandro D. Santin

Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors
Charles Li, Elena Bonazzoli, Stefania Bellone, Jungmin Choi, Weilai Dong, Gulden Menderes, Gary Altwerger, Chanhee Han, Aranzazu Manzano, Anna Bianchi, Francesca Pettinella, Paola Manara, Salvatore Lopez, Ghanshyam Yadav, Francesco Riccio, Luca Zammataro, Burak Zeybek, Yang Yang-Hartwich, Natalia Buza, Pei Hui, Serena Wong, Antonella Ravaggi, Eliana Bignotti, Chiara Romani, Paola Todeschini, Laura Zanotti, Valentina Zizioli, Franco Odicino, Sergio Pecorelli, Laura Ardighieri, Dan-Arin Silasi, and Babak Litkouhi

Isolated port site recurrence of node-negative clinical stage IB1 cervical adenocarcinoma
Uma Deshmukh, Molly McAdow, Jonathan Black, Pei Hui, and Masoud Azodi

Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin
Francesca Casagrande, Emiliano Cocco, Stefania Bellone, Christine E. Richter, Marta Bellone, Paola Todeschini, Eric Siegel, Joyce Varughese, Dan Arin-Silasi, Masoud Azodi, Thomas J. Rutherford, Sergio Pecorelli, Peter E. Schwartz, and Alessandro D. Santin

Financial toxicity in patients with gynecologic malignancies: a cross sectional study
Burak Zeybek, Emily Webster, Natalia Pogosian, Joan Tymon-Rosario, Alan Balch, Gary Altwerger, Mitchell Clark, Gulden Menderes, Gloria Huang, Masoud Azodi, Elena S. Ratner, Peter E. Schwartz, Alessandro D. Santin, and Vaagn Andikyan

Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancer
Emiliano Cocco, Erik M. Shapiro, Sara Gasparrini, Salvatore Lopez, Carlton L. Schwab, Stefania Bellone, Ileana Bortolomai, Natalia J. Sumi, Elena Bonazzoli, Roberta Nicoletti, Yang Deng, W Mark Saltzman, Caroline J. Zeiss, Floriana Centritto, Jonathan D. Black, Dan-Arin Silasi, Elena Ratner, Masoud Azodi, Thomas J. Rutherford, Peter E. Schwartz, Sergio Pecorelli, and Alessandro D. Santin

Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan
Burak Zeybek, Aranzazu Manzano, Anna Bianchi, Elena Bonazzoli, Stefania Bellone, Natalia Buza, Pei Hui, Salvatore Lopez, Emanuele Perrone, Paola Manara, Luca Zammataro, Gary Altwerger, Chanhee Han, Joan Tymon-Rosario, Gulden Menderes, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Masoud Azodi, Peter E. Schwartz, and Alessandro Santin

Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer
Benjamin B. Albright, Jonathan D. Black, Rachel Passarelli, Stefan Gysler, Margaret Whicker, Gary Altwerger, Gulden Menderes, Natalia Buza, Pei Hui, Alessandro D. Santin, Masoud Azodi, Dan-Arin Silasi, Elena S. Ratner, Babak Litkouhi, and Peter E. Schwartz

Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo
C L. Schwab, S Bellone, D P. English, D M. Roque, S Lopez, E Cocco, R Nicoletti, I Bortolomai, E Bonazzoli, E Ratner, D-A Silasi, M Azodi, P E. Schwartz, T J. Rutherford, and A D. Santin

A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma
Chanhee Han, Stefania Bellone, Eric R. Siegel, Gary Altwerger, Gulden Menderes, Elena Bonazzoli, Tomomi Egawa-Takata, Francesca Pettinella, Anna Bianchi, Francesco Riccio, Luca Zammataro, Ghanshyam Yadav, Jarrod A. Marto, Marie-France Penet, Douglas A. Levine, Ronny Drapkin, Abhijit Patel, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Masoud Azodi, Peter E. Schwartz, and Alessandro D. Santin

Randomized phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer (NCT03093155): Updated survival and subgroup analyses
Dana M. Roque, Eric R. Siegel, Natalia Buza, Stefania Bellone, Gloria S. Huang, Gary Altwerger, Vaagn Andikyan, Mitchell Clark, Masoud Azodi, Peter E. Schwartz, Gautam G. Rao, Elena Ratner, and Alessandro D. Santin

Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer
Dana M. Roque, Eric R. Siegel, Natalia Buza, Stefania Bellone, Dan-Arin Silasi, Gloria S. Huang, Vaagn Andikyan, Mitchell Clark, Masoud Azodi, Peter E. Schwartz, Gautam G. Rao, Jocelyn C. Reader, Pei Hui, Joan R. Tymon-Rosario, Justin Harold, Dennis Mauricio, Burak Zeybek, Gulden Menderes, Gary Altwerger, Elena Ratner, and Alessandro D. Santin

Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer
Dana M. Roque, Eric R. Siegel, Natalia Buza, Stefania Bellone, Dan-Arin Silasi, Gloria S. Huang, Vaagn Andikyan, Mitchell Clark, Masoud Azodi, Peter E. Schwartz, Gautam G. Rao, Jocelyn C. Reader, Pei Hui, Joan R. Tymon-Rosario, Justin Harold, Dennis Mauricio, Burak Zeybek, Gulden Menderes, Gary Altwerger, Elena Ratner, and Alessandro D. Santin

Vascular segmental exclusion for recurrent vulvar squamous cell carcinoma invading the femoral vessels
Andrew W. Schwartz, Masoud Azodi, Jonathan Cardella, and Cassius Iyad Chaar

The role of minimally invasive interval debulking surgery in advanced epithelial ovarian cancer
Gulden Menderes, Jonathan D. Black, and Masoud Azodi

Surgical and oncologic outcomes in surgically treated women 80 years and older with endometrioid endometrial cancer as a function of their comorbidities
Abdelrahman AlAshqar, Maddie Ghazarian, Emily M. Webster, Animesh Upadhyay, Masoud Azodi, Peter E. Schwartz, Elena Ratner, and Gary Altwerger